Carbylan Therapeutics, Inc. 4
4 · Carbylan Therapeutics, Inc. · Filed Aug 5, 2015
Insider Transaction Report
Form 4
Renzi David
DirectorPresident & CEO
Transactions
- Award
Stock Option (Right to Buy)
2015-08-03+276,506→ 276,506 totalExercise: $6.91Exp: 2025-08-03→ Common Stock (276,506 underlying)
Footnotes (1)
- [F1]The option shall vest with respect to 1/48 of the underlying shares upon each monthly anniversary of the vesting commencement date of August 1, 2015.